198 related articles for article (PubMed ID: 25232488)
1. GATA3 in the urinary bladder: suppression of neoplastic transformation and down-regulation by androgens.
Li Y; Ishiguro H; Kawahara T; Miyamoto Y; Izumi K; Miyamoto H
Am J Cancer Res; 2014; 4(5):461-73. PubMed ID: 25232488
[TBL] [Abstract][Full Text] [Related]
2. Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesis.
Kawahara T; Inoue S; Kashiwagi E; Chen J; Ide H; Mizushima T; Li Y; Zheng Y; Miyamoto H
Am J Cancer Res; 2017; 7(10):2041-2050. PubMed ID: 29119053
[TBL] [Abstract][Full Text] [Related]
3. ELK1 promotes urothelial tumorigenesis in the presence of an activated androgen receptor.
Inoue S; Ide H; Mizushima T; Jiang G; Kawahara T; Miyamoto H
Am J Cancer Res; 2018; 8(11):2325-2336. PubMed ID: 30555747
[TBL] [Abstract][Full Text] [Related]
4. Compound A inhibits urothelial tumorigenesis via both the androgen receptor and glucocorticoid receptor signaling pathways.
Ide H; Inoue S; Mizushima T; Jiang G; Nagata Y; Goto T; Kashiwagi E; Miyamoto H
Am J Transl Res; 2020; 12(5):1779-1788. PubMed ID: 32509176
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
Kawahara T; Kashiwagi E; Li Y; Zheng Y; Miyamoto Y; Netto GJ; Ishiguro H; Miyamoto H
Mol Carcinog; 2016 Feb; 55(2):161-9. PubMed ID: 25594762
[TBL] [Abstract][Full Text] [Related]
6. FOXO1 as a tumor suppressor inactivated via AR/ERβ signals in urothelial cells.
Ide H; Mizushima T; Jiang G; Goto T; Nagata Y; Teramoto Y; Inoue S; Li Y; Kashiwagi E; Baras AS; Netto GJ; Kawahara T; Miyamoto H
Endocr Relat Cancer; 2020 Apr; 27(4):231-244. PubMed ID: 32031965
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.
Izumi K; Zheng Y; Hsu JW; Chang C; Miyamoto H
Mol Carcinog; 2013 Feb; 52(2):94-102. PubMed ID: 22086872
[TBL] [Abstract][Full Text] [Related]
8. ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling.
Inoue S; Mizushima T; Ide H; Jiang G; Goto T; Nagata Y; Netto GJ; Miyamoto H
Endocr Connect; 2018 Dec; 7(12):1397-1408. PubMed ID: 30521479
[TBL] [Abstract][Full Text] [Related]
9. Role of glucocorticoid signaling in urothelial tumorigenesis: Inhibition by prednisone presumably through inducing glucocorticoid receptor transrepression.
Ide H; Inoue S; Mizushima T; Kashiwagi E; Zheng Y; Miyamoto H
Mol Carcinog; 2019 Dec; 58(12):2297-2305. PubMed ID: 31535408
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
[TBL] [Abstract][Full Text] [Related]
11. Protective role of mineralocorticoid receptor signaling in urothelial tumorigenesis.
Nagata Y; Matsukawa T; Goto T; Teramoto Y; Jiang G; Fujimoto N; Miyamoto H
Am J Cancer Res; 2023; 13(2):408-418. PubMed ID: 36895984
[TBL] [Abstract][Full Text] [Related]
12. Expression of UDP-glucuronosyltransferase 1A in bladder cancer: association with prognosis and regulation by estrogen.
Izumi K; Li Y; Ishiguro H; Zheng Y; Yao JL; Netto GJ; Miyamoto H
Mol Carcinog; 2014 Apr; 53(4):314-24. PubMed ID: 23143693
[TBL] [Abstract][Full Text] [Related]
13. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
[TBL] [Abstract][Full Text] [Related]
14. Latrophilin-3 as a downstream effector of the androgen receptor induces urothelial tumorigenesis.
Goto T; Yasui M; Teramoto Y; Nagata Y; Mizushima T; Miyamoto H
Mol Carcinog; 2024 Jun; ():. PubMed ID: 38925569
[TBL] [Abstract][Full Text] [Related]
15. Effects of α
Nagata Y; Kawahara T; Goto T; Inoue S; Teramoto Y; Jiang G; Fujimoto N; Miyamoto H
Am J Cancer Res; 2020; 10(12):4386-4398. PubMed ID: 33415006
[TBL] [Abstract][Full Text] [Related]
16. Loss of GATA3 in bladder cancer promotes cell migration and invasion.
Li Y; Ishiguro H; Kawahara T; Kashiwagi E; Izumi K; Miyamoto H
Cancer Biol Ther; 2014 Apr; 15(4):428-35. PubMed ID: 24448324
[TBL] [Abstract][Full Text] [Related]
17. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
Teng J; Wang ZY; Jarrard DF; Bjorling DE
Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.
Kashiwagi E; Inoue S; Mizushima T; Chen J; Ide H; Kawahara T; Reis LO; Baras AS; Netto GJ; Miyamoto H
Br J Cancer; 2018 Jan; 118(2):213-223. PubMed ID: 29123257
[TBL] [Abstract][Full Text] [Related]
19. Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice.
Johnson DT; Hooker E; Luong R; Yu EJ; He Y; Gonzalgo ML; Sun Z
PLoS One; 2016; 11(2):e0148851. PubMed ID: 26862755
[TBL] [Abstract][Full Text] [Related]
20. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.
Hsu JW; Hsu I; Xu D; Miyamoto H; Liang L; Wu XR; Shyr CR; Chang C
Am J Pathol; 2013 May; 182(5):1811-20. PubMed ID: 23499463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
